In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stepping Into the Race to Detect Fetal Cells in Maternal Blood

Executive Summary

Many companies have tried and failed to develop tools that could detect fetal cells in maternal blood. Their aim would be to detect pre-natal abnormalities more accurately and earlier than existing tests and to replace invasive methods, such as amniocentesis. Roche Diagnostics started a program in this field six years ago and found several markers distinguishing fetal from maternal cells in blood. But its priorities shifted and recently it licensed the technology to Vysis, which has been doing chromosomal analysis of fetal cells gleaned from amniocentesis

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

IV001752

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel